CME Learning Center

Leukemia and Myeloid Neoplasms

Test Your Skills: Case Challenges in Myelofibrosis CME / ABIM MOC How would you treat these patients with myelofibrosis?
Medscape_Education_No_Bots, November 2023
Fractionated vs Single-Dose Gemtuzumab Ozogamicin with Determinants of Benefit in Older Patients with AML: the UK NCRI AML18 Trial CME / ABIM MOC In older patients with AML, fractionated gemtuzumab increased response depth but not toxicity and improved survival in allografted patients.
Blood, November 2023
Managing Acute Lymphoblastic Leukemia With Asparaginase Therapies: Test Your Knowledge and Skills CME / ABIM MOC Do you know how to effectively integrate asparaginase formulations into the management of patients with acute lymphoblastic leukemia (ALL)?
Medscape_Education_No_Bots, November 2023
How to Effectively Manage Asparaginase Therapy in Acute Lymphoblastic Leukemia CE Are you aware of how to implement and manage the new asparaginase formulations into your clinical practice?
Medscape Education Oncology, October 2023
Higher-Risk Myelodysplastic Syndrome: An Interprofessional Tumor Board CME / ABIM MOC / CE Why do so many clinical trials of novel therapies fail in higher-risk myelodysplastic syndrome?
Medscape Education Oncology, October 2023
Exploring Emerging Approaches in Acute Myeloid Leukemia CME / CE Drs DiNardo, Erba, and Zeidan discuss recent data on the most promising emerging therapies in acute myeloid leukemia (AML).
Medscape Education Oncology, September 2023
Chronic Myeloid Leukemia: Keys to Navigating the Long Game With Your Patients CME / ABIM MOC / CE Are you and your patients sharing the decision-making about CML treatments?
Medscape Education Oncology, September 2023
Prevalence and Clinical Expression of Germ Line Predisposition to Myeloid Neoplasms in Adults With Marrow Hypocellularity CME / ABIM MOC A cohort study shows the spectrum, symptoms, and prevalence of germline predisposition mutations in adults with cytopenia/hypoplastic bone marrow.
Blood, August 2023
Myelofibrosis: Highlights From the Summer 2023 Meetings CME / ABIM MOC Dr Gerds reviews the biggest myelofibrosis news from American Society of Clinical Oncology (ASCO®) and European Hematology Association (EHA) 2023.
Medscape Education Oncology, July 2023
Spectrum of Clonal Hematopoiesis in VEXAS Syndrome CME / ABIM MOC UBA1^mut cells are the main cause of systemic inflammation/marrow failure in VEXAS, a new molecularly defined somatic entity linked to myelodysplastic syndrome (MDS).
Blood, July 2023
Optimal Management of Lower-Risk Myelodysplastic Syndromes: Expert Review CME / ABIM MOC What's the latest in lower-risk myelodysplastic syndrome (LR-MDS) management? Join as Dr Komrokji summarizes the latest data.
Medscape Education Oncology, July 2023
Phase 2 Clinical Trial Evaluating Abatacept in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease CME / ABIM MOC Abatacept’s safety, efficacy, and effect on the immune microenvironment in steroid-refractory cGVHD suggest it may be a promising treatment.
Blood, June 2023
Peer-to-Peer Connections: Exploring Optimal Myelofibrosis Management Strategies Together CME / ABIM MOC How do myelofibrosis experts personalize care for their patients?
Medscape Education Ophthalmology, June 2023
The Nurse View: Bringing Myelofibrosis Into Focus CE What should nurses know about caring for patients with myelofibrosis (MF)?
Medscape Education Oncology, May 2023
The Pharmacist View: Key Considerations for Optimal Myelofibrosis Management CE Did you know that the collaboration between the physician and the pharmacist will enhance the outcome for patients receiving treatment for myelofibrosis (MF)?
Medscape Education Pharmacists, April 2023
Advances in Myelofibrosis: Updates on Emerging Treatments and Future Directions CME / ABIM MOC Did you know new treatments in development are being developed for myelofibrosis with the goal of changing the disease course?
March 2023
Tyrosine Kinase Inhibitors: Optimizing Treatment Options for Patients With Chronic Myeloid Leukemia CME / ABIM MOC How do you choose a tyrosine kinase inhibitor (TKI) for your patients with chronic myeloid leukemia (CML)? Join to hear an expert discussion on considerations and clinical data.
Medscape Education Oncology, March 2023
Chronic Leukemias CME / ABIM MOC / CE Do you know the latest approaches to treating chronic leukemias?
Medscape Education Oncology, March 2023
Emerging Approaches to Myelofibrosis Management CME / ABIM MOC What’s new in the treatment of myelofibrosis (MF)? Join to hear an overview of the latest data on new and emerging agents.
Medscape Education Oncology, March 2023
Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Neoplasms CME / ABIM MOC / CE Expand your knowledge and skills by exploring the latest data on leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.
Medscape Education Oncology, February 2023

Are Black and Minority Groups Underrepresented in Oncology Clinical Trials? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, November 4, 2022
What Are the Risks of Transgender Hormone Therapy?
Medscape Education Clinical Briefs, May 21, 2021
Black Patients With AML in the US Have Worse Outcomes Compared With White Patients CME / ABIM MOC / CE
Medscape Education Clinical Briefs, February 3, 2021
Is Increase in Cancer Incidence Related to "Overdiagnosis"? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, November 21, 2019
Does Maternal Obesity Affect Childhood Cancer?
Medscape Education Clinical Briefs, August 16, 2019

CME Learning Center

Leukemia and Myeloid Neoplasms

Latest Clinical Briefs

About Leukemia and Myeloid Neoplasms

Further Reading